top | item 38647623

(no title)

kmanlives | 2 years ago

I have an autoimmune disease mentioned in the article. In looking through a group of which I am member I came across this interesting FDA alert about CAR-T therapy from a few weeks ago...

https://www.drugs.com/fda/fda-investigating-serious-risk-t-c...

discuss

order

purpleflame1257|2 years ago

This is quite possibly due to most of these patients already receiving DNA-damaging chemo before CAR-T therapy. It also represents only 20 cases out of tens of thousands of doses.

lstroud|2 years ago

myasthenia gravis patients already get chemo therapy to destroy their immune cells as part of the infusion protocols. That is a treatment and is not curative. If CAR-T works on MG, then it’s not the chemo that’s doing it.